London & Capital Asset Management LTD Abb Vie Inc. Transaction History

London & Capital Asset Management LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.7 Million - $2.11 Million	-12,883 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $3,760 - $4,757	-35 Reduced 0.27%	12,883 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.37 Million - $1.56 Million	12,918 New	12,918 $1.39 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $1.26 Million - $1.4 Million	-11,979 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $142,299 - $156,654	1,391 Added 13.14%	11,979 $1.3 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $852,228 - $1.15 Million	10,588 New	10,588 $1.14 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $566,662 - $665,074	-6,596 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $73,370 - $98,180	1,000 Added 17.87%	6,596 $648,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $2,596 - $3,249	36 Added 0.65%	5,596 $495,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $151,907 - $182,636	-2,412 Reduced 30.26%	5,560 $421,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $333,690 - $426,534	5,079 Added 175.56%	7,972 $580,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $18,976 - $22,334	246 Added 9.29%	2,893 $233,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $206,068 - $254,138	2,647 New	2,647 $244,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on London & Capital Asset Management LTD with notifications on news.